Citation

Sareen J, Chartier M, Paulus MP, Stein MB. Psychiatry Res. 2006; 142(1): 11-17.

Affiliation

Department of Psychiatry, University of Manitoba, PZ430-771 Bannatyne Avenue, Winnipeg, MB, Canada R3E 3N4. sareen@cc.umanitoba.ca

Copyright

(Copyright © 2006, Elsevier Publishing)

DOI

10.1016/j.psychres.2006.01.009

PMID

16712953

Abstract

The focus of this investigation was the relationship between anxiety disorders and lifetime use of amphetamines, cocaine, hallucinogens and heroin in two contemporaneous samples. Data from two independent community surveys conducted in the US (N=5877) and Ontario (N=8116) were used to assess whether a lifetime anxiety disorder diagnosis (social phobia, panic disorder, agoraphobia, specific phobia, and generalized anxiety disorder) was significantly associated with lifetime use of amphetamines, hallucinogens, cocaine, and heroin. Posttraumatic stress disorder was assessed only in the US survey. After controlling for sociodemographics, a significant association between any anxiety disorder diagnosis and lifetime stimulant use, cocaine use, and hallucinogen use was found in both surveys (OR approximately 1.5-3.0). Any anxiety disorder diagnosis was significantly associated with lifetime heroin use in the US survey (OR approximately 3.0). Clinicians and researchers need to be aware of the relationship between anxiety disorders and illicit drug use.

Language: en